Your cart

Upcoming Webinar: Clinical Significance of Ionized Magnesium in Critical Care

Blood gas Webinar Logo
Clinical Significance of Ionized Magnesium in Critical Care
Blood gas analyzers are essential devices in point-of-care settings such as respiratory care units, surgical suites, intensive care units, emergency rooms, and the central lab. An advanced menu of tests that includes glucose, lactate, ionized calcium, ionized magnesium, electrolytes, estimated plasma volume, BUN and creatinine along with blood gas provides important results at the point of care. This presentation will discuss the clinical value of having access to an advanced complement of blood test results and the significance of ionized magnesium results in critically ill patients.

Presenter

 

Presenter: Jessica Colon-Franco, PhD
Section Head, Clinical Biochemistry Medical Director,
Special Chemistry Department of Laboratory Medicine
Cleveland Clinic

Presenter



Presenter: Marcin Pacek
Medical and Scientific Affairs Director
Nova Biomedical

Date:
April 10 & April 24
TIme:
1PM EST / 3pm EST
Duration:
1 Hour
Register Here

Clinical Utility of Ionised Magnesium for Patients in Critical Care

Blood gas Webinar Logo
Clinical Utility of Ionised Magnesium for Patients in Critical Care
Magnesium, the second most abundant cation in our body and cofactor for over 600 enzymes. It is involved in controlling various important physiological processes such as antiarrhythmic action, vascular tone action, muscle contraction, glucose metabolism and insulin homeostasis. Monitoring blood magnesium levels is usually done by the total magnesium (tMg); however, the physiologically active fraction of the magnesium is the 'ionised magnesium (iMg).'

In this session, Dr Masaru Yamamoto will uncover the key differences between iMg and tMg, review literature on monitoring methods, and their impact on patient outcomes. Leveraging his extensive experience in clinical chemistry and medical affairs, and his distinguished background at Nova Biomedical, Dr Yamamoto will provide valuable insights into the latest research and its clinical implications.

Presenter

Presenter 1:

Dr Masaru Yamamoto Ph.D.
Director, Asia Pacific, Medical & Scientific Affairs (MASA)
Nova Biomedical

Presenter

Presenter 2:

Steve Mawditt (Moderator)
National Sales Manager ANZ Nova Biomedical

Date:
6 March 2025
TIme:
Sydney/Melbourne: 5.30PM
Brisbane: 4.30PM
Adelaide: 5.00PM
Perth: 2.30PM
Auckland, NZ: 7.30PM
Duration:
1 Hour
Register Here
Blood gas Webinar Logo
Clinical Utility of Ionised Magnesium for Patients in Critical Care
Magnesium, the second most abundant cation in our body and cofactor for over 600 enzymes. It is involved in controlling various important physiological processes such as antiarrhythmic action, vascular tone action, muscle contraction, glucose metabolism and insulin homeostasis. Monitoring blood magnesium levels is usually done by the total magnesium (tMg); however, the physiologically active fraction of the magnesium is the 'ionised magnesium (iMg).'

In this session, Dr Masaru Yamamoto will uncover the key differences between iMg and tMg, review literature on monitoring methods, and their impact on patient outcomes. Leveraging his extensive experience in clinical chemistry and medical affairs, and his distinguished background at Nova Biomedical, Dr Yamamoto will provide valuable insights into the latest research and its clinical implications.
Presenter
Presenter 1:

Dr Masaru Yamamoto Ph.D.
Director, Asia Pacific, Medical & Scientific Affairs (MASA)
Nova Biomedical

Presenter
Presenter 2:

Steve Mawditt
(Moderator) National Sales Manager ANZ
Nova Biomedical

Date:
6 February 2025
TIme:
Sydney/Melbourne: 7.00PM
Brisbane: 6.00PM
Adelaide: 6.30PM
Perth: 4.00PM
Auckland, NZ: 9.00PM
Duration:
1 Hour
Register Here

Ionized or Total Magnesium Levels, What Should We Measure in Critically Ill Patients?

Monitoring and measuring magnesium (Mg) values is essential to prevent the development of numerous complications in critically ill patients. This webinar will describe why Ionized Mg (iMg) may offer a more reliable indicator of Mg status during acute illness than total Mg (tMg) concentrations. Dr. Abdullah M. Al Alawi, Sr. Consultant, UMC, Muscat, Oman will discuss the incidence of dysmagnesemia and the relationship between iMg and tMg. The clinical and biochemical characteristics as well as health outcomes and their association with iMg and tMg will be addressed. Dr. Alawi will also describe the use of point-of-care devices for rapid assessment of iMg in critical situations.

PresenterPresenter: Dr. Abdullah M. Al Alawi, MD, BSc, MSc, FRACP, FACP

Sr. Consultant, UMC, Muscat, Oman
Program Director, Internal Medicine
Residency Program, Sultan Qaboos University Department of Medicine

 

PresenterPresenter: Dennis Begos, MD, FACS, FACRS

Senior Director
Medical and Scientific Affairs
Nova Biomedical

 

View here